September 25, 2017 |
Groundbreaking Collaboration and Cannabinoid Conference
October 25, 2016  | 

Philadelphia, PA – Temple University, a national leader in substance abuse research, has announced a groundbreaking collaboration with Thomas Jefferson University’s Center for Medical Cannabis Education & Research (“CMCER”), the nation’s first comprehensive resource for expert-developed, unbiased information about the medical uses of marijuana and cannabinoid focused-therapies to be housed within a major US health sciences university.

With the recent signing of PA Act 16, which legalized the use of medical marijuana for the adjunct treatment of specific medical conditions within Pennsylvania, new opportunities to address critical regional and state-wide health concerns are likely to emerge. Together, the institutions seek to encourage research and education initiatives involving physicians and scientists working within each respective institution and elsewhere in the Commonwealth and the nation.

To help kickoff this collaboration, Temple’s Lewis Katz School of Medicine and its Center for Substance Abuse Research and CMCER will be co-presenting the 2016 Carolina Cannabinoid Collective Conference on October 28th-30th. Over 100 of the country’s leading cannabinoid researchers will gather in Philadelphia to address recent developments and discoveries. The Conference will feature as its keynote speakers Donald Abrams, MD, Chief of Hematology-Oncology at Zuckerberg San Francisco General Hospital, and a member of CMCER’s international Academic Steering Committee, and Yasmin Hurd, PhD, Professor of Psychiatry, Neuroscience and Pharmacology and Systems Therapeutics, and Director of the Center for Addictive Disorders at the Icahn School of Medicine at Mount Sinai. Continue>

Page | 1 2 3
Suggested Articles